Codiak BioSciences (CDAK) executive Barna received 8,400 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Nicole Barna (executive at Codiak BioSciences Inc., CDAK) reported that they received 8,400 Stock Option (Right to Buy) on Feb 16, 2022.
- Reporting person
- Barna Nicole
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 16, 2022 | Grant or award (A) | Stock Option (Right to Buy)On 8,400 Common Stock1 | +8,400 | - | - | 8,400 direct |
| Feb 16, 2022 | Grant or award (A) | Restricted Stock UnitsOn 12,600 Common Stock2, 3 | +12,600 | - | - | 12,600 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 8,400 direct
- Restricted Stock Units: 0 to 12,600 direct
Footnotes from the filing
- 1. 25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
- 2. Each restricted stock unit represents a contingent right to receive one share of common stock.
- 3. On February 16, 2022, the reporting person was granted 12,600 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Barna report in this CDAK Form 4?
Nicole Barna (executive at Codiak BioSciences Inc., CDAK) reported that they received 8,400 Stock Option (Right to Buy) on Feb 16, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CDAK
Earlier insider filings at CDAK
- Feb 18, 2022SEC Form 4 filed by Haddock Jason
- Feb 7, 2022SEC Form 4: Barna Nicole bought $49,978 worth of shares (6,781 units at $7.37)
- Jan 21, 2022SEC Form 4 filed by Brudnick Richard
- Jan 21, 2022SEC Form 4 filed by Howze Yalonda
- Jan 21, 2022SEC Form 4 filed by Barna Nicole
Keep researching CDAK
- CDAK insider tradesEvery buy and sale reported by Codiak BioSciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
CDAK
Codiak BioSciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2020
Get push alerts for CDAK
Full CDAK profile on Quantisnow Follow CDAK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time